Correction: Efficacy and mechanism of action of harmine derivative H-2–104 against Echinococcus granulosus infection in mice

Correction: BMC Vet Res 21, 174 (2025)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12917-025–04642-x

Following publication of the original article [1], the authors, upon re-evaluation, they identified minor issues in Figs. 3A and 5, where some incorrect images were inadvertently used. This error does not affect the scientific conclusions of the study. The incorrect and correct figures are provided below.

Incorrect Fig. 3:

Fig. 3

A Effects of HM and H-2–104 on the tissue structure in healthy mice. Thirty days after treatment with HM and its derivatives, the mice were euthanized. HE staining was used to observe the histopathological changes in the livers, brains and kidneys of the mice. Bar = 10 μm. B Cyst size in mice after drug administration. C Cyst weight (mean ± SD), inhibition rate of capsule (mean ± SD), number of cysts(mean ± SD) and cyst diameter (mean ± SD) in mice (n = 6) *P < 0.05, **P < 0.01, ***P < 0.001

Correct Fig. 3:

Fig. 3

A Effects of HM and H-2–104 on the tissue structure in healthy mice. Thirty days after treatment with HM and its derivatives, the mice were euthanized. HE staining was used to observe the histopathological changes in the livers, brains and kidneys of the mice. Bar = 10 μm. B Cyst size in mice after drug administration. C Cyst weight (mean ± SD), inhibition rate of capsule (mean ± SD), number of cysts(mean ± SD) and cyst diameter (mean ± SD) in mice (n = 6) *P < 0.05, **P < 0.01, ***P < 0.001

Incorrect Fig. 5:

Fig. 5

Cyst ultrastructural changes. GL: Germinal layers; Te: tegument. Scale bar = 2 μm

Correct Fig. 5:

Fig. 5

Cyst ultrastructural changes. GL: Germinal layers; Te: tegument. Scale bar = 2 μm